The addition of H5 avian influenza detection to the Metrix® platform strengthens the nation's preparedness posture by enabling rapid, point-of-care differentiation of H5 from seasonal H1 and H3 ...
GOLETA, Calif., Sept. 16, 2026 /PRNewswire/ -- Aptitude today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the next-generation Metrix® COVID Test, ...
SANTA BARBARA, Calif., Feb. 24, 2025 /PRNewswire/ -- Aptitude Medical Systems, Inc. (Aptitude) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug ...
BURLINGTON, Mass., April 2, 2025 /PRNewswire/ -- SEKISUI Diagnostics, a global medical diagnostics manufacturer, announces the launch of the Metrix® COVID/Flu Test, the second assay on the Metrix® ...
SANTA BARBARA, Calif., July 30, 2025 /PRNewswire/ -- Aptitude Medical Systems, Inc. (Aptitude) today announced it has been awarded a contract modification worth up to $8.25M from the Biomedical ...
Metrix was designed to make high-performance molecular testing dramatically more accessible. Small enough to hold in your hand, Metrix is FDA-cleared for both over-the-counter and professional use in ...
SEKISUI Diagnostics, a global medical diagnostics manufacturer, announces the launch of the Metrix COVID/Flu Test, the second assay on the Metrix Molecular Platform for use at the point-of-care and in ...
First Metrix 510(k) clearance introduces improved sensitivity and speed as Aptitude grows its molecular diagnostics platform GOLETA, Calif., Sept. 16, 2026 /PRNewswire/ -- Aptitude today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results